Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study.

Add to Collection

2017 Oct Observational studies A Goyal, H Singh, VK Sehgal, CR Jayanthi… - The Indian Journal of …, 2017 - ncbi.nlm.nih.gov 21

Full Author : ['Goyal, Aman', 'Singh, Harmanjit', 'Sehgal, Vijay Kumar', 'Jayanthi, C R', 'Munshi, Renuka', 'Bairy, K Laxminarayana', 'Kumar, Rakesh', 'Kaushal, Sandeep', 'Kakkar, Ashish Kumar', 'Ambwani, Sneha', 'Goyal, Chhaya', 'Mazumdar, Goutameswar', 'Adhikari, Anjan', 'Das, Nina', 'Stephy, Divya John', 'Thangaraju, Pugazhenthan', 'Dhasmana, D C', 'Rehman, Shakil U', 'Chakrabarti, Amit', 'Bhandare, Basavaraj', 'Badyal, Dinesh Kumar', 'Kaur, Inderpal', 'Chandrashekar, K', 'Singh, Jagjit', 'Dhamija, Puneet', 'Sarangi, Sudhir Chandra', 'Gupta, Yogendra Kumar']
Journal Title : The Indian journal of medical research
Chapter : Section21, Section4
Journal Year : 2017
Cited by : 6

BACKGROUND & OBJECTIVES: Pioglitazone was suspended for manufacture and sale by the Indian drug regulator in June 2013 due to its association with urinary bladder carcinoma, which was revoked within a short period (July 2013). The present questionnaire-ba..... Read More

Keywords : ['multicentre questionnairebase observational study', 'antidiabetic drug among physician', 'regulatory spin', 'prescription', 'pioglitazone', 'india', 'impact']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819028/
Google Scholar Link : https://scholar.google.com/scholar?cites=4884830481873823094&as_sdt=5,44&sciodt=0,44&hl=en&num=20

Have a Question?

Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study.